← Back to Clinical Trials
Recruiting NCT06451029

NCT06451029 Prevention of Smoking Related Diseases

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06451029
Status Recruiting
Phase
Sponsor Scientific Institute San Raffaele
Condition Lung Cancer
Study Type OBSERVATIONAL
Enrollment 189 participants
Start Date 2022-01-11
Primary Completion 2025-12-31

Eligibility & Interventions

Sex All sexes
Min Age 50 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 189 participants in total. It began in 2022-01-11 with a primary completion date of 2025-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective, observational, monocentric study. This study wants to test if among a smoking cessation intervention, behavioural counselling by video session is related to higher compliance and higher success rate than standard smoking cessation activity (face to face counselling).

Eligibility Criteria

Inclusion Criteria: * Strong smokers (pack years \>= 20) * Over or equal the age of 50 * Able to sign specific informed consent for the study Exclusion Criteria: * Not having plans to quit smoking

Contact & Investigator

Central Contact

Pierluigi Novellis, Medical Doctor

✉ novellis.pierluigi@hsr.it

📞 +39 022643

Frequently Asked Questions

Who can join the NCT06451029 clinical trial?

This trial is open to participants of all sexes, aged 50 Years or older, studying Lung Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06451029 currently recruiting?

Yes, NCT06451029 is actively recruiting participants. Contact the research team at novellis.pierluigi@hsr.it for enrollment information.

Where is the NCT06451029 trial being conducted?

This trial is being conducted at Milan, Italy.

Who is sponsoring the NCT06451029 clinical trial?

NCT06451029 is sponsored by Scientific Institute San Raffaele. The trial plans to enroll 189 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology